Literature DB >> 1902197

Synthetic peptide substrates for the immunoglobulin A1 protease from Neisseria gonorrhoeae (type 2).

S G Wood1, J Burton.   

Abstract

Neisseria gonorrhoeae secretes protease which inactive human immunoglobulin A1 (IgA1) by cleavage of specific peptide bonds in the hinge region. The type 2 IgA1 protease (EC 3.4.24.13) is secreted as a 169-kDa precursor which undergoes autoproteolysis at three sites (A, B, and C) to release the 106-kDa active form of the enzyme (J. Pohlner, R. Halter, K. Beyreuther, and T. F. Meyer. Nature [London] 325:458-462, 1987). Synthetic decapeptides consisting of five residues on each side of the three autoproteolytic cleavage sites and their potential pentapeptide catabolites were prepared by solid-phase synthesis. Cleavage of the decapeptides by the type 2 IgA1 protease from N. gonorrhoeae was monitored by high-performance liquid chromatography. Peptides homologous with the amino acid sequences around the B and C sites are cleaved by the IgA1 protease. Amino acid analysis and Edman degradation show that the cleavage products have both the composition and amino acid sequence which would be expected from cleavage at the predicted sites. Km values of 1.35 mM and 3.43 mM and kcat values of 280 pmol/h/U and 439 pmol/h/U for the site B and site C peptides, respectively, were determined. The catalytic efficiency (kcat/Km) for the synthetic substrates is about 10% of that reported for intact IgA1. Cleavage of the peptides is inhibited by IgA1 protease inhibitors such as the tetrapeptide substrate analog inhibitor HRP-48, human colostrum, and a peptide-boronate transition state inhibitor. An extract from an N. gonorrhoeae construct lacking active IgA1 protease failed to cleave the synthetic substrate, while an extract from the control construct which secretes active enzyme completely hydrolyzed the synthetic peptide. Neither the site A peptide nor synthetic decapeptides encompassing cleavage sites in the hinge region of IgA1 are hydrolyzed by IgA1 protease. These are the first synthetic substrates to be reported for any IgA1 protease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902197      PMCID: PMC257921          DOI: 10.1128/iai.59.5.1818-1822.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Inhibition of IgA1 proteinases from Neisseria gonorrhoeae and Hemophilus influenzae by peptide prolyl boronic acids.

Authors:  W W Bachovchin; A G Plaut; G R Flentke; M Lynch; C A Kettner
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

2.  Assay and properties of IgA protease of Streptococcus sanguis.

Authors:  A G Plaut; J V Gilbert; I Heller
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

Review 3.  Secretory immunity and the bacterial IgA proteases.

Authors:  S J Kornfeld; A G Plaut
Journal:  Rev Infect Dis       Date:  1981 May-Jun

4.  Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease.

Authors:  J Pohlner; R Halter; K Beyreuther; T F Meyer
Journal:  Nature       Date:  1987 Jan 29-Feb 4       Impact factor: 49.962

5.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

6.  Tetrapeptide inhibitors of the IgA1 proteinases from type I Neisseria gonorrhoeae.

Authors:  S G Wood; M Lynch; A G Plaut; J Burton
Journal:  J Med Chem       Date:  1989-10       Impact factor: 7.446

7.  Inhibition of microbial IgA proteases by human secretory IgA and serum.

Authors:  J V Gilbert; A G Plaut; B Longmaid; M E Lamm
Journal:  Mol Immunol       Date:  1983-09       Impact factor: 4.407

8.  Substrate analogue inhibitors of the IgA1 proteinases from Neisseria gonorrhoeae.

Authors:  J Burton; S G Wood; M Lynch; A G Plaut
Journal:  J Med Chem       Date:  1988-08       Impact factor: 7.446

9.  IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies.

Authors:  M Kilian; J Mestecky; R Kulhavy; M Tomana; W T Butler
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

10.  IgA protease of Neisseria gonorrhoeae: isolation and characterization of the gene and its extracellular product.

Authors:  R Halter; J Pohlner; T F Meyer
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

View more
  3 in total

1.  Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases.

Authors:  Bernard W Senior; Jenny M Woof
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA.

Authors:  Koteswara R Chintalacharuvu; Philip D Chuang; Ashley Dragoman; Christine Z Fernandez; Jiazhou Qiu; Andrew G Plaut; K Ryan Trinh; Françoise A Gala; Sherie L Morrison
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease.

Authors:  Troy A Johnson; Jiazhou Qiu; Andrew G Plaut; Todd Holyoak
Journal:  J Mol Biol       Date:  2009-04-23       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.